OIG: Avastin a Better Buy for Wet AMD

WASHINGTON (MedPage Today) -- The Centers for Medicare and Medicaid Services should establish a national payment policy for bevacizumab (Avastin) to treat wet age-related macular degeneration, a government report concluded.